Profile data is unavailable for this security.
About the company
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s or other neuroinflammatory diseases (HT-ALZ). It also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for acne as well as inflammatory bowel diseases (HT-003). Its development products include HT-001, HT-KIT, HT-ALZ, and HT-TBI. Its BioLexa Platform is a proprietary, patented, drug compound platform for the treatment of eczema. The Company also has interests in certain other assets being developed by third parties including a treatment for patients with lupus.
- Revenue in USD (TTM)0.00
- Net income in USD-7.70m
- Incorporated2017
- Employees2.00
- LocationHoth Therapeutics Inc590 Madison Avenue, 21St FloorNEW YORK 10022United StatesUSA
- Phone+1 (646) 756-2997
- Websitehttps://hoththerapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scorpius Holdings Inc | 9.74m | -32.20m | 2.89m | 82.00 | -- | 0.0376 | -- | 0.2962 | -1.22 | -1.40 | 0.3663 | 0.7937 | 0.1372 | -- | 26.56 | 118,815.70 | -47.81 | -39.37 | -58.20 | -43.18 | 68.56 | -- | -348.43 | -1,068.21 | 0.2641 | -198.18 | 0.3179 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Onconetix Inc | 758.90k | -45.68m | 3.49m | 12.00 | -- | -- | -- | 4.59 | -2.41 | -2.41 | 0.0407 | 1.91 | 0.0156 | -- | 4.70 | 63,241.67 | -93.67 | -- | -137.89 | -- | -123.62 | -- | -6,019.45 | -- | 0.2752 | -17.12 | 0.2352 | -- | -- | -- | -176.78 | -- | -- | -- |
| Resonate Blends Inc | 101.41k | -4.72m | 3.52m | 6.00 | -- | -- | -- | 34.71 | -0.0537 | -0.0537 | 0.0012 | -0.0007 | 0.0328 | -- | -- | -- | -152.56 | -680.29 | -- | -- | -34.87 | -78.88 | -4,657.83 | -12,895.26 | -- | -0.7413 | 1.02 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
| Silo Pharma Inc | 72.12k | -3.53m | 3.55m | 3.00 | -- | 0.5154 | -- | 49.21 | -1.18 | -1.20 | 0.024 | 1.87 | 0.008 | -- | -- | 24,040.00 | -39.26 | -24.90 | -43.11 | -26.39 | 91.90 | 82.79 | -4,889.57 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
| Sentient Brands Holdings Inc | 0.00 | -818.63k | 3.86m | 2.00 | -- | -- | -- | -- | -0.0145 | -0.0145 | 0.00 | -0.036 | 0.00 | 0.0188 | -- | 0.00 | -317.87 | -220.36 | -- | -- | -- | 41.81 | -- | -31,451.19 | 0.0354 | -2.27 | -- | -- | -73.68 | -- | 34.98 | -- | -- | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 3.90m | -- | -- | -- | 2.57 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Clever Leaves Holdings Inc | 17.42m | -19.80m | 4.04m | 296.00 | -- | 0.1641 | -- | 0.2317 | -12.57 | -11.38 | 11.11 | 14.02 | 0.418 | 1.69 | 11.03 | 58,841.21 | -47.51 | -23.20 | -58.14 | -26.55 | 37.64 | -- | -113.66 | -207.52 | 1.63 | -3.70 | 0.0479 | -- | 6.14 | -- | 47.63 | -- | -- | -- |
| China Pharma Holdings Inc | 6.42m | -3.56m | 4.12m | 231.00 | -- | 0.4644 | -- | 0.6424 | -0.8352 | -0.8352 | 1.03 | 0.5596 | 0.3828 | 1.93 | 14.14 | 27,795.89 | -21.22 | -29.66 | -44.77 | -55.25 | -11.67 | 6.47 | -55.42 | -73.09 | 0.2523 | -11.34 | 0.261 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| Biofrontera Inc | 33.25m | -23.09m | 4.20m | 85.00 | -- | -- | -- | 0.1263 | -12.47 | -12.47 | 16.84 | -0.3627 | 0.9995 | 2.50 | 5.75 | 391,200.00 | -69.40 | -- | -144.06 | -- | 48.99 | -- | -69.44 | -- | 0.944 | -3.55 | 4.63 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| Hoth Therapeutics Inc | 0.00 | -7.70m | 4.25m | 2.00 | -- | 0.4891 | -- | -- | -2.02 | -2.02 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -70.17 | -157.07 | -77.15 | -177.32 | -- | -- | -- | -- | -- | -50.67 | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
| Evoke Pharma Inc | 6.11m | -7.13m | 4.64m | 4.00 | -- | 1.33 | -- | 0.7604 | -1.83 | -1.83 | 1.28 | 0.4068 | 0.5429 | 0.5113 | 5.71 | 1,526,428.00 | -63.39 | -100.48 | -76.67 | -151.10 | 96.01 | -- | -116.76 | -480.52 | 5.35 | -19.25 | 0.5884 | -- | 106.51 | -- | 5.25 | -- | -- | -- |
| Titan Pharmaceuticals Inc | 87.00k | -4.95m | 4.71m | 4.00 | -- | 0.7736 | -- | 54.12 | -6.41 | -6.41 | 0.1119 | 6.66 | 0.0197 | -- | 1.23 | 21,750.00 | -112.41 | -96.80 | -170.59 | -156.65 | -- | -- | -5,694.25 | -406.26 | -- | -415.19 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -9.83m | 4.94m | 13.00 | -- | 0.5562 | -- | -- | -6.29 | -6.29 | 0.00 | 3.11 | 0.00 | -- | -- | 0.00 | -87.82 | -84.35 | -102.32 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0012 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Hanyuan Biotech International Inc | 10.65m | 3.14m | 5.28m | -- | 0.0294 | 0.0064 | 1.45 | 0.4957 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Stemtech Corp | 4.64m | -4.08m | 5.63m | 45.00 | -- | -- | -- | 1.21 | -0.0624 | -0.0624 | 0.0619 | -0.0092 | 1.09 | 8.35 | 65.16 | 103,098.40 | -96.70 | -- | -- | -- | 76.09 | -- | -88.58 | -- | 0.1045 | -1.81 | 2.27 | -- | -- | -- | -- | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Hoth Therapeutics Inc's reporting currency: US Dollar USD
10.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Mar 2024 | 410.00k | 8.39% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 38.80k | 0.79% |
| Geode Capital Management LLCas of 31 Mar 2024 | 25.56k | 0.52% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 10.01k | 0.21% |
| Tower Research Capital LLCas of 31 Mar 2024 | 6.25k | 0.13% |
| UBS Financial Services, Inc.as of 31 Mar 2024 | 2.15k | 0.04% |
| Qube Research & Technologies Ltd.as of 31 Mar 2024 | 300.00 | 0.01% |
| Brewin Dolphin Wealth Management Ltd.as of 31 Mar 2024 | 240.00 | 0.01% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 34.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 4.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
